Defining the mutational profile of lower-risk myelodysplastic neoplasm patients with respect to disease progression using next-generation sequencing and pyrosequencing
Monika Adamska(Poznan University of Medical Sciences), Lidia Gil(Poznan University of Medical Sciences), Joanna Czerwińska-Rybak(Poznan University of Medical Sciences), Katarzyna Kiwerska(Institute of Human Genetics), Katarzyna Brzeźniakiewicz‐Janus(University of Zielona Góra), Aleksandra Łanocha(Pomeranian Medical University), Weronika Gronowska(Poznan University of Medical Sciences), Małgorzata Jarmuż‐Szymczak(Poznan University of Medical Sciences), Marta Barańska(Poznan University of Medical Sciences), Ewa Wasilewska(Medical University of Silesia), Jagoda Loba(Poznan University of Medical Sciences), Ewelina Kowal-Wiśniewska(Poznan University of Medical Sciences)
Cited by 0
Related Papers
Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score
|Medical Oncology|2017|49
Age-dependent determinants of infectious complications profile in children and adults after hematopoietic cell transplantation: lesson from the nationwide study
|Annals of Hematology|2019|49
<i>Demodex folliculorum</i>and<i>Demodex brevis</i>in healthy and immunocompromised patients
|Ophthalmic Epidemiology|2013|45
The Prevalence of Blastocystis hominis and Other Protozoan Parasites in Soldiers Returning from Peacekeeping Missions
|American Journal of Tropical Medicine and Hygiene|2015|28